Eligibility
Study Procedures
IP / Pharmacy
Imaging
Labs
100

Both protocols require a histologically confirmed diagnosis of these types of cancer

What is Squamous and Non-Squamous NSCLC?

100

Efficacy assessments that should be performed before any other visit procedures

What are the PROs? (Patient Reported Outcomes / questionnaires)

100

The storage temperature of the investigational product

What is stored at 2 to 8°C?

100

These imaging criteria are used by the investigator and Blinded Independent Central Review (BICR) to determine response

What is RECIST v1.1?

100

If a urine dipstick shows proteinuria of ≥2+, this quantitative confirmatory assessment must be performed

What is a 24-hour quantitative urine protein analysis? (with ratio-based UPCR as the acceptable alternative)

200

It must be 0 or 1 for a participant to be eligible for in either study

What score of the ECOG PS is needed to be eligible?

200

Blood pressure must be measured after the participant has been resting quietly for at least this many minutes

What is 5 minutes?

200

Participants weighing ≥50 kg receive this dose of pumitamig

What is 1,500 mg?

200

The scanning procedure required for brain imaging (unless contraindicated)

What is an MRI?

200

The two frequency options for shipping samples to the central labs

What are: (1) Same‑day shipping for ambient samples and 

(2)monthly shipping for frozen samples?

300

This type of tumor sample is not accepted for central lab submission

What is a cytologic tumor sample?

300

(S)AEs must be reported until this many days following treatment discontinuation or the last visit, whichever is latest

What is 90 days?

300

Pumitamig is administered as an IV infusion over this duration

What is 60 minutes?

300

The investigator must wait for this confirmation before discontinuing treatment

What is Blinded Independent Central Review (BICR) confirmation of progressive disease (PD)?

300

Screening laboratory assessments (hematology, chemistry, and urinalysis) are to be performed within this many days before randomization

What is 14 days?

400

These are the only antiplatelet or anticoagulant treatments allowed

What is prophylactic low-dose aspirin (≤100 mg/day) or clopidogrel (<75 mg/day)?

400

Type of search performed by Omnitrace for patient who fully withdrew consent

What is a survival status search?

400

A pumitamig dose adjustment is triggered when  these criteria are met

What is a ≥10% change in body weight from baseline for 2 consecutive visits?

400

Partial Response (PR) and Complete Response (CR) must be confirmed at least this many days after the initial response

What is 28 days?

400

The timeframe under which screening labs can be carried forward to the first treatment visit (C1D1) without repeating

What is within 72 hours prior to randomization?

500

Both protocols exclude participants whose creatinine clearance level is below this measure. (Cockcroft-Gault formula)

What is 40 mL/min?

500

The Patient Reported Outcomes (PRO)/questionnaire to be completed before the other ones

What is NSCLC-SAQ?

500

Once the pumitamig infusion is prepared, these are the two permissible storage options and their maximum time limits

What are:

(1) room temperature for < 4 hours; and 

(2) 2–8 °C for < 24 hours?

500

CT images must be acquired with a slice thickness of this measurement or less

What is 5 mm?

500

These 2 lab criteria trigger a potential drug-induced liver injury (DILI) SAE?

What are (1) ALT or AST >3× ULN, combined with 

(2) total bilirubin >2× ULN? (no findings of cholestasis) 

M
e
n
u